INDSWFTLABPharmaceuticals

Ind Swift Laboratories LtdQuarterly Results & Earnings

131.43
+0.97%
Profit Growth YoY1848.78%Latest quarter
Sales Growth YoY1176.25%Latest quarter
Sales CAGR 5Y-6.35%5 year compound
Profit CAGR 5Y15.81%5 year compound
📋

Quarterly Performance

YoY Profit Growth+1848.78%
🔥 Exceptional growth
YoY Sales Growth+1176.25%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
16.66%
EPS Growth 5Y
15.79%
Interest Coverage
Higher = safer debt servicing
1.17
ROE
0.18%
ROCE
0.78%
💡

Growth Analysis

Ind Swift Laboratories Ltd reported YoY profit growth of 1848.78% and revenue growth of 1176.25% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at -6.35% and profits at 15.81% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.